| Line Item | 2025-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $4.8M | — | -37.6% |
| R&D Expense | $1.7M | — | +271.6% |
| SG&A Expense | $483K | — | +0.0% |
| Operating Income | -$44.2M | — | -462.2% |
| Interest Expense | $4.8M | — | +2217.8% |
| Pre-tax Income | -$53.0M | — | -561.0% |
| Income Tax | $24K | — | -36.0% |
| Net Income | -$53.1M | — | -558.2% |
| EPS (Basic) | -$0.32 | — | -190.9% |
| EPS (Diluted) | -$0.32 | — | -190.9% |
| Line Item | 2025-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $2.1M | -30.5% | -0.4% |
| Accounts Receivable | $1.1M | -60.6% | -35.4% |
| Current Assets | $18.3M | -24.1% | -20.9% |
| Total Assets | $45.4M | -10.1% | -25.6% |
| Current Liabilities | $312.6M | +5.7% | +550.3% |
| Total Liabilities | $312.9M |
| Line Item | 2025-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$16.2M | — | -135.9% |
| Investing Cash Flow | $1.5M | — | -29.6% |
| Financing Cash Flow | $11.7M | — | +235.0% |
| +436.0% |
| Stockholders' Equity | -$267.4M | -8.7% | -9846.3% |